
AI, Cancer Vaccines, and the Future of Personalized Medicine | Sid Sijbrandij on GitLab + Biotech
Episode 63
Can AI help design personalized cancer vaccines? Visit Future of Cancer Care Today: https://sijbrandijfoundation.org/fcct In this episode, we speak with Sid Sijbrandij, founder of GitLab who went "Founder Mode" against his own cancer. Sid discusses personalized cancer vaccines, tumor sequencing, immunotherapy, and the challenge of making cutting-edge cancer treatments accessible to patients outside traditional clinical trials. We explore how personalized mRNA cancer vaccines work, from sequencing a tumor and identifying mutations that distinguish cancer cells from healthy cells to selecting tumor-specific antigens that can be encoded into an mRNA vaccine. Sid explains why this approach is fundamentally different from conventional chemotherapy and why engaging the patient's own immune system could give immunotherapies the potential to produce durable or even curative responses. Sid also describes his own experience combining multiple experimental treatment modalities, including personalized mRNA vaccines, immunotherapies, and radioligand therapy. He explains how radioligands can use molecular binders to selectively deliver radiation to tumor tissue, and how modifying the tumor microenvironment may make cancers more susceptible to subsequent immune therapies. We also discuss why personalized cancer vaccines remain difficult and expensive to manufacture.
Publisher
632nm
Link
share.transistor.fm/s/99edb650
Published
October 6, 2026
Duration
1h 41m
Format
Podcast
Category
Issues · Science
Source
RSS feed
Host
Misha Shalaginov, Michael Dubrovsky, Xinghui Yin
632nm
@632nm
#cancervaccines #personalizedmedicine #sidsijbrandij #naturalsciences
